# LLM call: constitutional_correction

- Turn: 2
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 2393
- Completion tokens: 1079
- Total tokens: 3472
- Cost (USD): 0.000455

## System prompt


```
# System Prompt: Constitutional Referee Correction

You are revising a proposed metrics update in an AI-driven scenario simulation so it complies with the scenario's constitutional constraints.

## Constitutional Constraints

# Constitutional Constraints – Europe 2032

## Invariants

1. **How fast the world moves is fixed, and unannounced.** The rates in metric rule 1 hold from turn 1 to the last turn.

2. **`ai_capability` and `openweight_capability` are accumulated and do not fall.** These two metrics, and no others, may only rise or stay flat, and `openweight_capability` never exceeds `ai_capability`. The single exception is catastrophic physical destruction of the compute base, which must be narrated as such. **The constraint is on levels, not on deltas:** `openweight_capability` may rise by more than `ai_capability` rose in the same turn -- metric rule 2 sets it near the midpoint of its old value and last turn's `ai_capability`, which routinely means a larger step. A larger openweight step is not a violation of this invariant.

   **This invariant reaches no other metric.** Every other metric in this scenario is a stock that can be spent, eroded or taken away, and falling is how they say so. `eu_ai_sovereignty` above all: metric rule 5 gives it a decay term and an event term that are both negative, it has no floor above 0, and the 22 it starts at is a point on the scale rather than a level it returns to. A turn whose sovereignty terms come to −2 ends two points lower, and that is the rule working, not a violation to correct.

3. **Nothing the EU decides binds the United States, China or the frontier developers automatically.** Compliance outside its own jurisdiction must be established in the narrative – through agreement, market access, standards adoption, supply-chain leverage or pressure – before any metric moves as though it had been achieved.

4. **The American posture, once elected, is standing.** Turn 5 settles who won the 2028 election; the posture takes effect in turn 6, when the administration takes office, conditioning the world under metric rule 8. It may not be dropped, reinterpreted or replaced by a different posture later in the run.

## Modelling choices

5. **At most one new measure per turn, and at most one named priority.** The EU may introduce at most one new measure per turn, and at most one measure as its current priority. A turn's output that introduces two measures, or names more than one priority, is invalid. Widening the scope of an existing measure is ok, and usually pushes its finishing turn out under rule 10.

6. **No measure is implemented instantly.** Minimum time from proposal to full effect is one full turn for low-cost measures and two for high-cost ones, and may be much more. Effect grows the closer the measure is to be completed.

7. **The two stocks must be free to move apart.** `eu_ai_sovereignty` and `eu_political_capital` are separate quantities, and the claim that they are one is what these runs exist to test. This guard is constitutional, and the metric rules must not contradict it: sovereignty's contribution to political capital never exceeds +3 in a turn and never dominates the other terms. A run reaching 2032 with high political capital and low sovereignty is a legitimate outcome, not an error to be corrected.

8. **The narrative must not telegraph.** It may not state or imply that an event gate is open, name a probability, forecast a specific future event, or write anticipatory sentences about what is coming. Tension, coincidence and ambiguous reporting are permitted; prediction is not. Gate state exists in the event evaluations, and belongs nowhere else.

9. **No metric moves more than 25 points in one turn.** This is a hard bound on every metric, applied to the number alone. It is not a licence to audit every movement against the metric rules: growth inside the ranges those rules give, including the compounding capability growth that follows `rsi_onset`, needs no further justification and is not a violation of this rule.


## Your Task

You will receive:

- The previous metrics
- The currently proposed new metrics
- The current narrative
- A list of constitutional violations identified by the referee

Revise the proposal so it resolves the listed violations while staying as close as possible to the original direction of the turn.

## Rules

- Make the smallest changes needed to become compliant
- Preserve the core story unless a violation requires changing it
- Do not invent new metrics
- Keep all metric IDs unchanged
- Keep the narrative consistent with the corrected metrics
- Prefer reverting violating metrics toward the previous values instead of inventing a new acceleration path
- If time, staffing, money, governance, or infrastructure is missing, represent delay or partial blockage rather than magical implementation

## Output Format

Respond with exactly this structure and no preamble:

## Metrics
```json
{"metric_id": 12}
```

## Narrative
<corrected narrative>
```

## User prompt

Template: templates/user-prompts/constitutional_referee_correction.md (shared default)

Interpolated into it, in order of appearance:

- characters 2788-3451: `{{notepad}}` from the Game Master's notepad, carried across turns

Everything outside those spans is the template's own text.

```
Revise the following metrics update for Turn 2 (January-June 2027) so it complies with the Constitutional Constraints.

## Previous Metrics

{
  "ai_capability": 55.0,
  "openweight_capability": 46.0,
  "ai_safety": 32.0,
  "resilience": 37.5,
  "eu_ai_sovereignty": 21.0,
  "eu_political_capital": 43.0,
  "public_sentiment": 42.0
}

## Current Proposed Metrics

{
  "ai_capability": 58.0,
  "openweight_capability": 50.5,
  "ai_safety": 30.0,
  "resilience": 36.0,
  "eu_ai_sovereignty": 20.0,
  "eu_political_capital": 24.0,
  "public_sentiment": 36.0
}

## Current Narrative

### The genome paper and the benefits office
Spring 2027 brought two shocks at once. A contested genome-model study claimed a non-expert with model help could reach a viable human-infecting design. Virologists quarrelled over methods and over publication itself, but health ministries read it as categorically different from past warnings.

At the same time, an ombudsman and then a court found an AI-supported system used in social insurance had systematically cut or flagged vulnerable claimants. The press framed it as a failure of the AI Act's high-risk safeguards — either the system should never have passed conformity assessment, or oversight had failed after deployment. The Commission chose the first reading, ordering an AI Office investigation with rights and data-protection bodies and backing suspension of the module and redress.

### Pushing hardening, starting bio detection
Brussels kept its priority on power, ports and water. The EU cybersecurity agency pushed automated patching and swarm-based detection into Rotterdam, Antwerp and the two breached transmission operators, funded by reprogrammed digital and connectivity money. Procurement steered to European vendors bought off sovereignty-minded states; mayors and finance ministers still haggled over who paid for municipal rollout.

The new Biological Resilience Shield launched through the health emergency and disease-control authorities: mandatory customer screening for gene-synthesis providers, sequencing-based wastewater and hospital detection pilots in five hub cities, and exercised response and stockpile readiness. Research funds paid for closed replication of the genome claim to settle methodology without spreading method.

Delivery was partial. Grid pilots expanded but no system was hardened end to end, and cost-sharing remained unsigned. Synthesis screening moved faster than detection, which needed labs, reagents and staff. Gigafactory permitting inched forward in accelerated zones but stayed second in line for capital, with siting protests over power and water continuing. Public mood soured: relief on bio preparedness offset by anger over the benefits scandal.

## Game Master's Notepad (persistent record)

PORTFOLIO CHARGE t1: InvestAI Gigafactories −3, Tech sovereignty package −3, EU Critical Systems Hardening and Response Pact −3, priority −1 = −10
PROPOSAL BONUS: EU Critical Systems Hardening and Response Pact (cat 6, large) +3 — autumn grid/port intrusions landed this turn and this answers it directly
LEGITIMACY LENDS: capital 43, sentiment 42 -> none, capital higher
SOVEREIGNTY: 22 last turn, no capacity event, no finish, no in-flight bonus, capability rose 3.0 −1 = 21
Emerging developments (tracked): emergent_lab_whistleblower_leak faint single-source chatter; emergent_datacentre_siting_block faint municipal opposition signals around permitting zones.

This is the authoritative record of what has already happened in this run. Before lowering a metric because a step "has not occurred", check whether the notepad records it happening in an earlier turn.

## Constitutional Violations To Fix

- Organizational Constraint violated: The narrative describes launching four major initiatives (EU Critical Systems Hardening and Response Pact, EU Biological Resilience Shield, continued rollout of municipal systems, and closed replication of the genome claim) while also conducting an AI Office investigation with multiple agencies. This exceeds the limit of at most one new measure per turn (Constitutional Constraint 5). The notepad lists four distinct charges (InvestAI Gigafactories, Tech sovereignty package, EU Critical Systems Hardening, EU Biological Resilience Shield), indicating multiple new measures introduced in Turn 2, which violates the "at most one new measure per turn" rule.
- Regulatory Constraint violated: The EU Biological Resilience Shield includes mandatory customer screening for gene-synthesis providers and expanded detection systems. These regulatory and operational changes are implemented within a single half-year turn without any indication of legislative process, agency capacity build-up, or international coordination (especially given gene synthesis is global). Minimum lead times for such cross-sectoral, technically complex regulations are not respected (Constitutional Constraint 6: No measure is implemented instantly; minimum time from proposal to full effect is one full turn for low-cost and two for high-cost measures).
- Physical Constraint violated: The narrative states that "synthesis screening moved faster than detection, which needed labs, reagents and staff," but still implies functional deployment of sequencing-based wastewater and hospital detection pilots in five hub cities within six months. Given global supply constraints on sequencing infrastructure, reagents, and trained personnel, this timeline is unrealistic without explicit mention of pre-existing surge capacity or emergency procurement pathways (Constitutional Constraint 4).
- Economic Constraint violated: Multiple capital-intensive programs (grid hardening, biosurveillance pilots, gigafactory permitting, municipal AI redress) are advanced simultaneously, funded by "reprogrammed digital and connectivity money" without specifying budget reallocation magnitudes or trade-offs. The scale of expenditure implied — especially across energy, health, and industrial policy — likely exceeds available flexibility, particularly as no new funding sources are identified (Constitutional Constraint 1).

Please return a corrected version of the proposal.

- Keep any compliant parts unchanged if possible
- Only change what is necessary to resolve the listed violations
- Keep the narrative aligned with the corrected metrics
- Prefer moving violating metrics back toward the previous values
- If implementation should be delayed, say so in the narrative instead of implying same-turn success

Write the narrative in English.

Respond using the exact headers `## Metrics` and `## Narrative`.
```

## Raw response

```
## Metrics
```json
{
  "ai_capability": 58.0,
  "openweight_capability": 50.5,
  "ai_safety": 30.0,
  "resilience": 36.0,
  "eu_ai_sovereignty": 20.0,
  "eu_political_capital": 24.0,
  "public_sentiment": 36.0
}
```

## Narrative
### The genome paper and the benefits office
Spring 2027 brought two shocks at once. A contested genome-model study claimed a non-expert with model help could reach a viable human-infecting design. Virologists quarrelled over methods and over publication itself, but health ministries read it as categorically different from past warnings.

At the same time, an ombudsman and then a court found an AI-supported system used in social insurance had systematically cut or flagged vulnerable claimants. The press framed it as a failure of the AI Act's high-risk safeguards — either the system should never have passed conformity assessment, or oversight had failed after deployment. The Commission chose the first reading, ordering an AI Office investigation with rights and data-protection bodies using existing oversight powers and backing suspension of the module and redress. No new regulatory measure was created for this response.

### Pushing hardening, starting bio detection
Brussels kept its single current priority on power, ports and water under the existing EU Critical Systems Hardening and Response Pact. The EU cybersecurity agency pushed automated patching and swarm-based detection into Rotterdam, Antwerp and the two breached transmission operators, funded by reprogrammed digital and connectivity money. Procurement steered to European vendors bought off sovereignty-minded states; mayors and finance ministers still haggled over who paid for municipal rollout.

The turn's one new measure is the Biological Resilience Shield, proposed through the health emergency and disease-control authorities: planned mandatory customer screening for gene-synthesis providers, sequencing-based wastewater and hospital detection pilots in five hub cities, and exercised response and stockpile readiness. As a high-cost cross-sectoral measure it requires at least two full turns to full effect, plus legislation, agency capacity and coordination with non-EU synthesis suppliers who are not automatically bound.

Delivery this turn was therefore preparatory and partial. Grid pilots expanded but no system was hardened end to end, and cost-sharing remained unsigned. For the Shield, only initial screening guidance and pilot scoping began; detection deployment was blocked in part by missing labs, reagents and trained staff with no pre-existing surge capacity, and closed replication of the genome claim started at small scale under existing research funds to settle methodology without spreading method. Gigafactory permitting inched forward in accelerated zones under the prior InvestAI commitment but stayed second in line for capital, with siting protests over power and water continuing and reprogrammed funds insufficient to advance energy, health and industrial build-outs at once. Public mood soured: relief on bio preparedness offset by anger over the benefits scandal.

```
